Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018221551) LEWY BODY DISEASE THERAPEUTIC AGENT CONTAINING PYRAZOLOQUINOLINE DERIVATIVE
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/221551 International Application No.: PCT/JP2018/020650
Publication Date: 06.12.2018 International Filing Date: 30.05.2018
IPC:
A61K 31/4745 (2006.01) ,A61P 25/16 (2006.01) ,C07D 471/04 (2006.01)
[IPC code unknown for A61K 31/4745][IPC code unknown for A61P 25/16][IPC code unknown for C07D 471/04]
Applicants:
エーザイ・アール・アンド・ディー・マネジメント株式会社 EISAI R&D MANAGEMENT CO., LTD. [JP/JP]; 東京都文京区小石川四丁目6番10号 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 1128088, JP
Inventors:
宮本 舞 MIYAMOTO Mai; JP
石川 幸雄 ISHIKAWA Yukio; JP
Agent:
長谷川 芳樹 HASEGAWA Yoshiki; JP
清水 義憲 SHIMIZU Yoshinori; JP
木元 克輔 KIMOTO Kosuke; JP
Priority Data:
62/513,72701.06.2017US
Title (EN) LEWY BODY DISEASE THERAPEUTIC AGENT CONTAINING PYRAZOLOQUINOLINE DERIVATIVE
(FR) AGENT THÉRAPEUTIQUE CONTENANT UN DÉRIVÉ DE PYRAZOLOQUINOLINE POUR TRAITER LA MALADIE À CORPS DE LEWY
(JA) ピラゾロキノリン誘導体を含有するレビー小体病治療剤
Abstract:
(EN) Provided is a Lewy body disease therapeutic agent that contains (S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quinolin-4(5H)-one, which is represented by formula (I), or a pharmaceutically acceptable salt thereof.
(FR) L'invention concerne un agent thérapeutique pour le traitement de la maladie à corps de Lewy, cet agent contenant de la (S)-7-(2-méthoxy-3,5-diméthylpyridin-4-yl)-1-(tétrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quinolin-4(5H)-one, qui est représentée par la formule (I), ou un sel pharmaceutiquement acceptable de celle-ci.
(JA) 式(I)で表される(S)-7-(2-メトキシ-3,5-ジメチルピリジン-4-イル)-1-(テトラヒドロフラン-3-イル)-1H-ピラゾロ[4,3-c]キノリン-4(5H)-オン またはその薬剤学的に許容される塩を含有するレビー小体病治療剤の提供。
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)